phenyl acetate has been researched along with rupatadine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Didiodato, G; Gerard, L; Hopkins, S; Kotchetkov, R; McLean, J; Nay, D | 1 |
| El-Ghany, SEA; Hegazy, SK; Kotkata, FAE; Mostafa, TM | 1 |
1 trial(s) available for phenyl acetate and rupatadine
| Article | Year |
|---|---|
Comparative study evaluating antihistamine versus leukotriene receptor antagonist as adjuvant therapy for rheumatoid arthritis.
Topics: Acetates; Adult; Arthritis, Rheumatoid; Body Mass Index; C-Reactive Protein; Clusterin; Cyclopropanes; Cyproheptadine; Double-Blind Method; Drug Therapy, Combination; E-Selectin; Egypt; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Interleukins; Leukotriene Antagonists; Male; Methotrexate; Middle Aged; Quinolines; Sulfides | 2021 |
1 other study(ies) available for phenyl acetate and rupatadine
| Article | Year |
|---|---|
Premedication with montelukast and rupatadine decreased rituximab infusion time, rate, severity of reactions and use of rescue medications.
Topics: Acetaminophen; Acetates; Adult; Aged; Aged, 80 and over; Cyclopropanes; Cyproheptadine; Diphenhydramine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Middle Aged; Premedication; Quinolines; Rituximab; Standard of Care; Sulfides; Treatment Outcome | 2020 |